For best experience please turn on javascript and use a modern browser!
Bekijk de site in het Nederlands

Breast cancer is the most common type of cancer in women in the Netherlands. Increasingly, systemic chemotherapy is given prior to surgery. This strategy, known as neoadjuvant chemotherapy, aims to eliminate metastases and reduce tumours, facilitating breast conserving surgery. MRI is increasingly used to evaluate response to chemotherapy in breast cancer patients. Claudette Loo investigates the role played by MRI in monitoring the response to neodjuvant chemotherapy, with the ultimate aim of improving personalised cancer treatment.

Event details of Role of MRI in neoadjuvant chemotherapy
Date 28 September 2016
Time 11:00 -12:00
Location Aula - Oude Lutherse kerk
Room Location

C.E.  Loo: Dynamic Contrast-Enhanced MRI for Monitoring Response to Neoadjuvant Chemotherapy in Breast Cancer

Supervisors

Prof. R.G.H. Beets-Tan

Prof. S. Rodenhuis

Co-supervisor

Dr K.G.A. Gilhuijs

Aula - Oude Lutherse kerk

Room Location

Singel 411
1012 XM Amsterdam

Entrance

This event is open to the public.